Report ID: SQMIG30A2012
Report ID:
SQMIG30A2012 |
Region:
Global |
Published Date: November, 2024
Pages:
165
|
Tables:
97 |
Figures:
76
Global Clinical Nutrition Market size was valued at USD 35.6 billion in 2022 and is poised to grow from USD 38.7 billion in 2023 to USD 71.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).
A clinical nutrition product helps the metabolic system work better by giving the body what it needs, like minerals, vitamins, and other nutrients that improve patients’ health. Clinical nutrition is the study and treatment of diseases that affect food intake, digestion, and metabolism. It also aims to improve health by preventing diseases that are caused by eating habits. It is used in many situations, such as cardiac rehabilitation, renal dialysis, diabetes, pediatrics, nutrition support, cancer, trauma, wellness centers, and community-based intervention programs.
As lifestyle-related diseases like inflammatory bowel disease and diabetes rise, so does the number of people who need clinical nutrition. An increasing number of older people and government investments in research and development in the health care sector also help the clinical nutrition market growth. Also, growing demand for clinical nutrition in emerging markets like Asia-Pacific and Latin America and a rise in the use of nutritional products in-home care are likely to make the global clinical nutrition market an attractive investment destination during the analysis period.
US Clinical Nutrition Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG30A2012